The Human Chorionic Gonadotropin (HCG) Market is divided into recombinant technology and natural source extraction based on technology. In 2017, the natural source extraction segment held a sizable portion of the global market, and it is anticipated that it will continue to dominate during the projected period. The leading companies in the hCG market demonstrate a strong demand for gonadotropins derived from natural sources, which represents a significant market trend in recent years and has significantly boosted this segment's income. For instance, gonadotropins that are derived from natural sources are offered by Sanzyme Ltd. However, due to the availability of recombinant hCGs in various forms, the recombinant technology sector is anticipated to increase at the highest rate from 2018 to 2025.
Read more @ https://creativeedge16.blogspot.com/2022/10/human-chorionic-gonadotropin-hcg-market.html
